<DOC>
	<DOCNO>NCT02152800</DOCNO>
	<brief_summary>The purpose study compare safety efficacy Vacyless速 Valtrex速 patient acute herpes zoster .</brief_summary>
	<brief_title>A Study Vacyless速 Versus Valtrex速 Patients With Herpes Zoster</brief_title>
	<detailed_description>Primary Endpoint : - Lesion assessment - Rash severity , term rash count Secondary Endpoints : - Pain assessment - Clinical global impression - Safety information valacyclovir</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<criteria>Men woman 20 80 year age . Patients clinical diagnosis HZ evidence unilateral dermatomal rash . Patients zosterrelated rash ( rash severity great equal mild ) . Patients able enrol study 72 hour appearance rash ( example , lesion vesicle ) . Patients provide write informed consent . Patients able complete study visit per protocol . Men premenopausal woman must agree practice barrier method birth control use spermicide one month last dose study drug ( oral contraceptive permit ) . Subject withdrew study contraception faild . Women pregnant lactating . Patients multidermatomal disseminate HZ ( great 20 lesion beyond dermatome adjacent primarily involve dermatome ) . Patients HZ ophthalmicus , define cutaneous lesion dermatome associate ophthalmic division trigeminal nerve Patients history impaired renal function , ( e.g. , calculated creatinine clearance le 50 mL/min/1.73 m2 ) Patients take narcotic analgesic routinely chronic pain condition Patients take tricyclic antidepressant Patients receive systemic antiviral activity VZV within past 30 day , topical antiviral treat current HZ Patients immunosuppressive immunodeficient condition result : disease ( e.g. , HIV ) corticosteroid use ( except intermittent topical/inhaled beclomethasone dipropionate equivalent &lt; 800 mcg/day ) , immunosuppressive/cytotoxic therapy ( cancer chemotherapy organ transplantation ) Patients condition ( e.g. , extensive psoriasis , chronic pain syndrome , cognitive impairment ) , opinion site investigator , might interfere evaluation require study Patients ambulatory ( bedridden homebound ) ; hospitalize patient may enrol ambulatory able complete study requirement Patients history allergy valacyclovir hydrochloride acetaminophen Patients unlikely adhere protocol followup</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>